brentuximab vedotin
seagen
[]
#17icml . dr. illidge presenting data about bv+chep (plus ethoposide). alcl 94% crr, non-alcl 73%. interestingly the density of cd30 is importante. les than 9% the rate response is 64%, but over 9% the rate response is 81%. hematological toxicity is frecuente 
Happily married. Hematologist & SC Transplanter. field of interest: lymphoma-myeloma &chemoresistance biomarkers. @HematoClinicBCN @hematosantpau.@GELL01433166